TABLE 3.
OXA-14 and OXA-935 induction increase ceftazidime resistance in PAO1 and PA14
Ceftazidime MICs (μg/mL) |
|||||
---|---|---|---|---|---|
mM IPTG | 0 | 0.25 | 0.5 | 0.75 | 1 |
PAO1 + pPSV37 | 1 | 1 | 1 | 1 | 1 |
PAO1 + pPSV37-oxa10 | 1 | 1 | 1 | 1 | 1 |
PAO1 + pPSV37-oxa14 | 1 | 8 | 8 | 16 (ns) | 16 (ns) |
PAO1 + pPSV37-oxa935 | 2 | 16 (ns)a | 16 (ns) | 32 (ns) | 32 (ns) |
PA14 + pPSV37 | 1 | 1 | 1 | 1 | 1 |
PA14 + pPSV37-oxa10 | 1 | 1 | 1 | 1 | 1 |
PA14 + pPSV37-oxa14 | 4 | 8 | 16 (ns) | 16 (ns) | 16 (ns) |
PA14 + pPSV37-oxa935 | 8 | 16 (ns) | 32 (ns) | 32 (ns) | 32 (ns) |
(ns), nonsusceptible (intermediate and resistant).